Private equity-firm, TPG Capital, has entered into a definitive agreement to acquire US-based Par Pharmaceutical for US $1.9 billion. Under terms of the agreement, Par stockholders will receive US ...

Par Pharmaceutical Companies has announced that its licensing partner, Aveva Drug Delivery Systems, has received final approval from the ...

However, in the interim, the US Food and Drug Administration (FDA) has relaxed regulations and turned to drug companies Apotex and Par Pharmaceuticals to help fill the gap. Currently, the FDA tells ...